Literature DB >> 17584349

An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand.

Suparpit Maneesakorn1, Deborah Robson, Kevin Gournay, Richard Gray.   

Abstract

AIM: The aim of this paper was to evaluate the effectiveness of adherence therapy-a brief intervention based on compliance therapy and motivational interviewing techniques-in a sample of people with schizophrenia in Thailand.
BACKGROUND: Poor adherence is problematic, but knowledge about how to improve medication adherence is limited. Studies focusing on the effects of interventions used to improve adherence have produced inconsistent outcomes and have been mainly conducted in western countries.
METHODS: An exploratory single blind randomized controlled trial was conducted in Chiang Mai, Thailand. Thirty-two patients with schizophrenia were randomly allocated to receive eight weekly sessions of adherence therapy or continue with their treatment as usual. Patients were assessed at baseline and after nine weeks. The primary outcome was overall psychotic symptoms. Secondary outcomes were general functioning, attitude towards and satisfaction with antipsychotic medication and medication side effects.
RESULTS: The findings of this study indicated that patients who received adherence therapy significantly improved in overall psychotic symptoms, attitude towards and satisfaction with medication compared with treatment as usual but no significant difference was found in general functioning or side effects compared with treatment as usual. RELEVANCE TO CLINICAL PRACTICE: Adherence therapy has a positive impact on patients' psychiatric symptoms, attitude towards and satisfaction with medication. Nurses can effectively deliver adherence therapy following intensive training.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17584349     DOI: 10.1111/j.1365-2702.2007.01786.x

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  14 in total

1.  Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies.

Authors:  John M Kane; Taishiro Kishimoto; Christoph U Correll
Journal:  World Psychiatry       Date:  2013-10       Impact factor: 49.548

2.  The effect of motivational interviewing on medication adherence and hospitalization rates in nonadherent patients with multi-episode schizophrenia.

Authors:  Emile Barkhof; Carin J Meijer; Leo M J de Sonneville; Don H Linszen; Lieuwe de Haan
Journal:  Schizophr Bull       Date:  2013-09-26       Impact factor: 9.306

3.  A cross-cultural three-step process model for assessing motivational interviewing treatment fidelity in Thailand.

Authors:  Juline A Koken; Sylvie Naar-King; Sanya Umasa; Jeffrey T Parsons; Pichai Saengcharnchai; Praphan Phanuphak; Chokechai Rongkavilit
Journal:  Health Educ Behav       Date:  2012-01-06

4.  The use of carer assisted adherence therapy for people with Parkinson's disease and their carers (CAAT-PARK): study protocol for a randomised controlled trial.

Authors:  David J Daley; Katherine Ho Deane; Richard J Gray; Paul F Worth; Allan B Clark; Kanagasabesan Sabanathan; Michael Pfeil; Phyo K Myint
Journal:  Trials       Date:  2011-11-28       Impact factor: 2.279

Review 5.  Strategies to improve medication adherence in patients with schizophrenia: the role of support services.

Authors:  Peggy El-Mallakh; Jan Findlay
Journal:  Neuropsychiatr Dis Treat       Date:  2015-04-16       Impact factor: 2.570

6.  Effects of motivational interviewing-based adherence therapy for schizophrenia spectrum disorders: a randomized controlled trial.

Authors:  Wai Tong Chien; Jolene H C Mui; Eric F C Cheung; Richard Gray
Journal:  Trials       Date:  2015-06-14       Impact factor: 2.279

7.  Packages of care for schizophrenia in low- and middle-income countries.

Authors:  Mari Jair de Jesus; Denise Razzouk; Rangaswamy Thara; Julian Eaton; Graham Thornicroft
Journal:  PLoS Med       Date:  2009-10-20       Impact factor: 11.069

8.  Effect of a system-oriented intervention on compliance problems in schizophrenia: a pragmatic controlled trial.

Authors:  Hanne Skarsholm; Henrik Stoevring; Bent Nielsen
Journal:  Schizophr Res Treatment       Date:  2014-06-02

9.  Efficacy of shared decision making on treatment satisfaction for patients with first-admission schizophrenia: study protocol for a randomised controlled trial.

Authors:  Mio Ishii; Yasuyuki Okumura; Naoya Sugiyama; Hana Hasegawa; Toshie Noda; Yoshio Hirayasu; Hiroto Ito
Journal:  BMC Psychiatry       Date:  2014-04-14       Impact factor: 3.630

Review 10.  Promotion, prevention and protection: interventions at the population- and community-levels for mental, neurological and substance use disorders in low- and middle-income countries.

Authors:  Inge Petersen; Sara Evans-Lacko; Maya Semrau; Margaret M Barry; Dan Chisholm; Petra Gronholm; Catherine O Egbe; Graham Thornicroft
Journal:  Int J Ment Health Syst       Date:  2016-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.